Title: Ablation of the inflammatory enzyme myeloperoxidase mitigates features of Parkinson's disease in mice.

Authors: Choi, Dong-Kug; Pennathur, Subramaniam; Perier, Celine; Tieu, Kim; Teismann, Peter; Wu, Du-Chu; Jackson-Lewis, Vernice; Vila, Miquel; Vonsattel, Jean-Paul; Heinecke, Jay W; Przedborski, Serge

Published In J Neurosci, (2005 Jul 13)

Abstract: Parkinson's disease (PD) is characterized by a loss of ventral midbrain dopaminergic neurons, which can be modeled by the neurotoxin 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP). Inflammatory oxidants have emerged as key contributors to PD- and MPTP-related neurodegeneration. Here, we show that myeloperoxidase (MPO), a key oxidant-producing enzyme during inflammation, is upregulated in the ventral midbrain of human PD and MPTP mice. We also show that ventral midbrain dopaminergic neurons of mutant mice deficient in MPO are more resistant to MPTP-induced cytotoxicity than their wild-type littermates. Supporting the oxidative damaging role of MPO in this PD model are the demonstrations that MPO-specific biomarkers 3-chlorotyrosine and hypochlorous acid-modified proteins increase in the brains of MPTP-injected mice. This study demonstrates that MPO participates in the MPTP neurotoxic process and suggests that inhibitors of MPO may provide a protective benefit in PD.

PubMed ID: 16014720

MeSH Terms: No MeSH terms associated with this publication